FDA Inspection
Yung Shin Pharmaceutical Industry Co., Ltd.Yung Shin Pharmaceutical Industry Co., Ltd. – FDA Inspection, Jul 27, 2018
Record Details
This FDA Inspection record concerns Yung Shin Pharmaceutical Industry Co., Ltd., with an inspection on July 27, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 30efab8d-ed52-47f1-866b-2a7f1395efa7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1062411
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Yung Shin Pharmaceutical Industry Co., Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 7, 2026 | Not classified | Office of Inspections and Investigations | |
| April 25, 2024 | Not classified | Office of Inspections and Investigations | |
| October 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| November 24, 2016 | Not classified | Office of Inspections and Investigations |
Other documents for Yung Shin Pharmaceutical Industry Co., Ltd.
- FDA Inspection 1338914 - 2026-08-07
- FDA Inspection 1238384 - 2024-04-25
- FDA Inspection 1111111 - 2019-10-22
- FDA Inspection 1101829 - 2019-09-12
- FDA Inspection 997026 - 2016-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.